APA (7th ed.) Citation

E, J., V, K., J, C., CS, F., C, L., RM, H., . . . L, S. (2023). Maternal Anti-Ro Antibody Titers Obtained With Commercially Available Immunoassays Are Strongly Associated With Immune-Mediated Fetal Heart Disease. Arthritis & rheumatology (Hoboken, N.J.), 75(9), 1556. https://doi.org/10.1002/art.42513

Chicago Style (17th ed.) Citation

E, Jaeggi, Kulasingam V, Chen J, Fan CS, Laskin C, Hamilton RM, Hiraki LT, Silverman ED, and Sepiashvili L. "Maternal Anti-Ro Antibody Titers Obtained With Commercially Available Immunoassays Are Strongly Associated With Immune-Mediated Fetal Heart Disease." Arthritis & Rheumatology (Hoboken, N.J.) 75, no. 9 (2023): 1556. https://doi.org/10.1002/art.42513.

MLA (9th ed.) Citation

E, Jaeggi, et al. "Maternal Anti-Ro Antibody Titers Obtained With Commercially Available Immunoassays Are Strongly Associated With Immune-Mediated Fetal Heart Disease." Arthritis & Rheumatology (Hoboken, N.J.), vol. 75, no. 9, 2023, p. 1556, https://doi.org/10.1002/art.42513.